Pulse Biosciences (PLSE) Free Cash Flow (2015 - 2025)

Pulse Biosciences' Free Cash Flow history runs 11 years deep, the most recent figure standing at -$14.6 million for Q4 2025.

• In Q4 2025, Free Cash Flow fell 59.96% year-over-year to -$14.6 million; the TTM figure through Dec 2025 stood at -$54.1 million (down 48.84% YoY), while the FY2025 annual figure was -$54.1 million, down 48.84% from the prior year.
• Free Cash Flow was -$14.6 million for Q4 2025 at Pulse Biosciences, down from -$13.2 million in the prior quarter.
• In the past five years, Free Cash Flow ranged from a high of -$6.6 million in Q1 2023 to a low of -$16.5 million in Q2 2021.
• Historically, Free Cash Flow has averaged -$11.3 million across 5 years, with a median of -$11.2 million in 2021.
• The sharpest annual moves came in 2021 and 2023: Free Cash Flow plunged 109.21% in 2021, then jumped 58.36% in 2023.
• A 5-year view of Free Cash Flow shows it stood at -$12.8 million in 2021, then surged by 37.59% to -$8.0 million in 2022, then climbed by 14.75% to -$6.8 million in 2023, then tumbled by 33.3% to -$9.1 million in 2024, then tumbled by 59.96% to -$14.6 million in 2025.
• The last three Free Cash Flow figures came in at -$14.6 million (Q4 2025), -$13.2 million (Q3 2025), and -$12.8 million (Q2 2025), per Business Quant data.